Through-focus energy efficiency and longitudinal chromatic aberration of three presbyopia-correcting intraocular lenses

Abstract

Purpose: To compare the chromatic performance of the Bausch & Lomb Versario 3F trifocal intraocular lens (IOL) with the PhysIOL FineVision MicroF trifocal IOL and the Johnson & Johnson Vision TECNIS Symfony ZXR00 extended range of vision (ERV) IOL. Methods: The through-focus energy efficiency (TF-EE) was measured in vitro with red (R), green (G), and blue (B) wavelengths and was used to obtain the focus powers and longitudinal chromatic aberrations (LCAs) for each IOL. Other metrics, derived from the RGB TF-EE curves, were assessed for a more complete description of the chromatic performance of the IOLs. Results: Both of the trifocal IOLs, although not specifically designed to tackle chromatic aberrations, showed acceptable LCA (≤0.50 D) in all foci with more balanced R and B efficiencies of their foci. Despite having the lowest TF-EE value at all foci, the Versario 3F demonstrated the most balanced chromatic performance with the smoothest energy transition among all foci and the smallest chromatic span. The Symfony lens effectively reduced LCA at distance and intermediate foci (≤0.36 D), despite the unbalanced and asymmetric R and B efficiencies at its foci. Conclusions: To fully describe the chromatic performance of an IOL it is necessary to take into account not only the LCA but also the RGB TF-EE and chromatic span. This comprehensive analysis suggests that, in comparison with the other IOLs under study, the Versario 3F lens might contribute to further mitigating the impact of chromatic aberration. Translational Relevance: The in vitro bench testing of the optical properties of modern presbyopia-correcting intraocular lenses (more specifically in this work, the polychro-matic through-focus energy efficiency and longitudinal chromatic aberration) provides objective and complementary information that helps to interpret the visual quality outcomes of pseudophakic patients obtained in clinics.